Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-10-24

FDA Approved: ISONIAZID — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for isoniazid submitted by Teva Pharmaceuticals USA, Inc. (ANDA 080937).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ISONIAZID (ISONIAZID)

Snippet

SUPPL AP for ISONIAZID (ISONIAZID)